A Silent Threat is Sweeping New Jersey: RSV on the Rise
Respiratory Syncytial Virus (RSV) is silently spreading across New Jersey, leaving many families on edge. While often dismissed as a common cold, this highly contagious virus can have devastating consequences, especially for the most vulnerable among us. But here's where it gets concerning: RSV is currently surging in more than half of New Jersey's counties, with emergency room visits reaching alarming levels.
According to the Centers for Disease Control and Prevention (CDC), RSV typically arrives in the fall and peaks during winter months. However, data reveals a worrying trend: ER visits and hospitalizations linked to RSV have been climbing in New Jersey since early October. As of January 31st, the virus has led to 304 hospitalizations statewide, predominantly affecting children under 4 and adults over 65.
And this is the part most people miss: While most cases present as mild cold-like symptoms, RSV can be life-threatening for infants, particularly those born prematurely or with underlying health conditions. Shockingly, the CDC reports that 2-3 out of every 100 infants under 6 months are hospitalized with RSV annually, and tragically, anywhere from 100 to 300 children succumb to the virus each year in the United States.
The good news? We have tools to fight back. The CDC recommends a vaccine for pregnant women, which can protect their newborns, or a monoclonal antibody treatment directly administered to infants. These antibodies, clesrovimab and nirsevimab, act as a shield against severe RSV disease in vulnerable babies.
Public health experts also urge vaccination for individuals aged 50-74 with chronic heart or lung conditions, residents of long-term care facilities, and everyone aged 75 and older. A single dose of the RSV vaccine provides protection for at least two years.
Despite these recommendations, vaccination rates remain concerning. As of December 2025, only 43.4% of adults aged 75 and older and 30.6% of those aged 50-74 at high risk had received the RSV vaccine.
Is enough being done to protect our most vulnerable from this preventable threat? The rising RSV cases in New Jersey demand our attention and action. Let’s spark a conversation: What more can be done to increase awareness and access to RSV prevention measures? Share your thoughts in the comments below.
